Literature DB >> 7371845

The occurrence of III3-alpha-fucosyllactoneotetraosylceramide in human brain.

M T Vanier, J E Månsson, L Svennerholm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7371845     DOI： 10.1016/0014-5793(80)80130-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  3 in total

1.  Characterization of SSEA-1 glycolipids from the brain of a patient with fucosidosis.

Authors:  G A Schwarting; M A Williams; J E Evans; R H McCluer
Journal:  Glycoconj J       Date:  1989       Impact factor: 2.916

2.  Stage-specific expression of fuco-neolacto- (Lewis X) and ganglio-series neutral glycosphingolipids during brain development: characterization of Lewis X and related glycosphingolipids in bovine, human and rat brain.

Authors:  S Dasgupta; E L Hogan; S S Spicer
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

3.  Expression of neolactoglycolipids: sialosyl-, disialosyl-, O-acetyldisialosyl- and fucosyl- derivatives of neolactotetraosyl ceramide and neolactohexaosyl ceramide in the developing cerebral cortex and cerebellum.

Authors:  D K Chou; Y Suzuki; F B Jungalwala
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.